ELEVAI Labs Inc
NASDAQ:ELAB
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
Bank of America Corp
NYSE:BAC
|
US |
|
Mastercard Inc
NYSE:MA
|
US |
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
Pfizer Inc
NYSE:PFE
|
US |
|
Nike Inc
NYSE:NKE
|
US |
|
Visa Inc
NYSE:V
|
US |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
Coca-Cola Co
NYSE:KO
|
US |
|
Verizon Communications Inc
NYSE:VZ
|
US |
|
Chevron Corp
NYSE:CVX
|
US |
|
Walt Disney Co
NYSE:DIS
|
US |
|
PayPal Holdings Inc
NASDAQ:PYPL
|
US |
P/E
Price to Earnings (P/E) ratio shows how much investors pay for each dollar of a company`s earnings. It`s calculated by dividing the company`s market value by its total earnings.
Price to Earnings (P/E) ratio shows how much investors pay for each dollar of a company`s earnings. It`s calculated by dividing the company`s market value by its total earnings.
Valuation Scenarios
If P/E returns to its Industry Average (15.5), the stock would be worth $-192.1 (7 815% downside from current price).
| Scenario | P/E Value | Implied Price | Upside/Downside |
|---|---|---|---|
| Current Multiple | -0.2 | $2.49 |
0%
|
| Industry Average | 15.5 | $-192.1 |
-7 815%
|
| Country Average | 22.9 | $-282.97 |
-11 464%
|
Forward P/E
Today’s price vs future net income
Peer Comparison
| Market Cap | P/E | ||||
|---|---|---|---|---|---|
| US |
E
|
ELEVAI Labs Inc
NASDAQ:ELAB
|
4.8m USD | -0.2 | |
| US |
|
Kenvue Inc
NYSE:KVUE
|
33.5B USD | 22.8 | |
| KR |
A
|
APR Co Ltd
KRX:278470
|
16.8T KRW | 58.4 | |
| BR |
|
Natura &Co Holding SA
OTC:NTCOY
|
7.7B USD | -4.4 | |
| KY |
H
|
Herbalife Ltd
XMUN:HOO
|
4.6B EUR | 23.5 | |
| CN |
M
|
Mao Geping Cosmetics Co Ltd
HKEX:1318
|
36.6B HKD | 26.5 | |
| KR |
d
|
d'Alba Global Co Ltd
KRX:483650
|
3T KRW | 37.8 | |
| CN |
|
Runben Biotechnology Co Ltd
SSE:603193
|
10.6B CNY | 34.8 | |
| IN |
H
|
Honasa Consumer Ltd
NSE:HONASA
|
113.5B INR | 72.9 | |
| IL |
O
|
Oddity Tech Ltd
NASDAQ:ODD
|
924.7m USD | 8.3 | |
| ID |
|
Industri Jamu dan Farmasi Sido Muncul Tbk PT
IDX:SIDO
|
14.5T IDR | 11.8 |
Market Distribution
| Min | 0 |
| 30th Percentile | 15.3 |
| Median | 22.9 |
| 70th Percentile | 33.2 |
| Max | 1 826 183.3 |
Other Multiples
ELEVAI Labs Inc
Glance View
ELEVAI Labs Inc is a US-based company operating in Personal Care Products industry. The company is headquartered in Newport Beach, California. The company went IPO on 2023-11-21. Elevai Labs, Inc. is a physician-dispensed skincare company. The firm conducts research and development to advance science-driven topical skincare that complements the medical aesthetics industry. The company produces and commercializes topical skincare products that contain its proprietary stem cell derived Elevai Exosomes designed to enhance the appearance of skin. Its Precision Regenerative Exosome Technology (PREx) biotechnology process yields exosome lots from human umbilical cord-derived mesenchymal stem cells (hUMSC) for its specialty physician-dispensed skincare products. The company has integrated the use of stem cell exosomes into its initial product line: Elevai Post Treatment E-Series. The E-Series comprises two post-skincare procedure care products that target the face and neck, and upper chest regions. Its products include Empower and Enfinity serums. Empower is its after-treatment topical product that supports the appearance of healthy skin and promotes an even toned complexion.
